Results 141 to 150 of about 20,576 (195)

Real-world treatment outcomes of aflibercept versus bevacizumab for neovascular age-related macular degeneration. [PDF]

open access: yesGraefes Arch Clin Exp Ophthalmol
Mhmud H   +8 more
europepmc   +1 more source

Intravitreal aflibercept 8 mg in patients from Japan with neovascular age-related macular degeneration: 48-week subgroup analysis of the PULSAR trial. [PDF]

open access: yesJpn J Ophthalmol
Koizumi H   +19 more
europepmc   +1 more source

Aflibercept 8 mg in Polypoidal Choroidal Vasculopathy: Post Hoc Analysis of the PULSAR Randomized Clinical Trial.

open access: yesJAMA Ophthalmol
Lee WK   +15 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy